A phase 3b, open-label, randomized, parallel-group, multi-center study to evaluate the safety of Novartis MenACWY conjugate vaccine when administered with routine infant vaccinations to healthy infants,
Role: Investigator,
Novartis Vaccines and Diagnostics, Inc.,
(01/2011 - 01/2012)
Status: Completed
A phase 3, open-label trial evaluating the safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy children, aged 15 months to 17 years in the United States,
Role: Investigator,
Wyeth Pharmaceuticals, Inc.,
(09/2010 - 09/2011)
Status: Completed
A phase 2, randomized, active-controlled, observer-blinded trial, to assess the safety, tolerability, and immunogenicity of MCV4, Tdap vaccine and rLP2086 vaccine when administered concomitantly in healthy aged = 10 to < 13 years,
Role: PI,
Pfizer Pharmaceuticals,
Status: Completed
Song-Brown Healthcare Workforce Training Program Grant-THC SACHS,
Role: Faculty,
Office of Statewide Health Planning and Development,
(01/2020 - 09/2021)
Status: Closed